Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

327 ARTÍCULOS , VIENDO DEL 46 AL 60

[Aspects of sustainability in outpatient health care for demented individuals]

Baumgardt J, Radisch J, Touil E, Moock J, Plewig HJ, Kawohl W, Rössler W.

Psychiatr Prax. 2014 Nov;41(8):424-31. doi: 10.1055/s-0033-1359974. Epub 2014 Mar 18.

Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics

Schwarz CG, Reid RI, Gunter JL, Senjem ML, Przybelski SA, Zuk SM, Whitwell JL, Vemuri P, Josephs KA, Kantarci K, Thompson PM, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 Jul 1;94:65-78. doi: 10.1016/j.neuroimage.2014.03.026. Epub 2014 Mar 18.

Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyond

Greig NH, Lahiri DK.

Curr Alzheimer Res. 2014 Feb;11(2):107-9. doi: 10.2174/156720501102140313162901.

[Aspects of quality of life of residents of a nursing oasis from the perspectives of relatives and nurses- qualitative results of an evaluation study]

Brandenburg H, Adam-Paffrath R, Güther H.

Pflege. 2014 Apr;27(2):69-80. doi: 10.1024/1012-5302/a000347.

Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease

Hayne DJ, Lim S, Donnelly PS.

Chem Soc Rev. 2014 Oct 7;43(19):6701-15. doi: 10.1039/c4cs00026a. Epub 2014 Mar 27.

Apathy in Alzheimer's disease: any effective treatment?

Rea R, Carotenuto A, Fasanaro AM, Traini E, Amenta F.

ScientificWorldJournal. 2014 Feb 2;2014:421385. doi: 10.1155/2014/421385. eCollection 2014.

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D.

Expert Opin Pharmacother. 2014 May;15(7):913-25. doi: 10.1517/14656566.2014.902446. Epub 2014 Mar 27.

Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease

Carman AJ, Dacks PA, Lane RF, Shineman DW, Fillit HM.

J Nutr Health Aging. 2014 Apr;18(4):383-92. doi: 10.1007/s12603-014-0021-7.

Towards a better life with Alzheimer's disease

Lancet. 2014 Mar 29;383(9923):1100. doi: 10.1016/S0140-6736(14)60548-1.

Neuroimaging in dementia

Valkanova V, Ebmeier KP.

Maturitas. 2014 Oct;79(2):202-8. doi: 10.1016/j.maturitas.2014.02.016. Epub 2014 Mar 12.

Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy

Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC.

Gerontologist. 2014 Dec;54(6):1049-58. doi: 10.1093/geront/gnu018. Epub 2014 Mar 31.

The relevance of short-range fibers to cognitive efficiency and brain activation in aging and dementia

Gao J, Cheung RT, Chan YS, Chu LW, Mak HK, Lee TM.

PLoS One. 2014 Apr 2;9(4):e90307. doi: 10.1371/journal.pone.0090307. eCollection 2014.

Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

Bron EE, Steketee RM, Houston GC, Oliver RA, Achterberg HC, Loog M, van Swieten JC, Hammers A, Niessen WJ, Smits M, Klein S; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2014 Sep;35(9):4916-31. doi: 10.1002/hbm.22522. Epub 2014 Apr 3.

Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease

He XP, Deng Q, Cai L, Wang CZ, Zang Y, Li J, Chen GR, Tian H.

ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5379-82. doi: 10.1021/am5010909. Epub 2014 Apr 8.

Tracking the earliest pathologic changes in Alzheimer disease

Landau SM, Frosch MP.

Neurology. 2014 May 6;82(18):1576-7. doi: 10.1212/WNL.0000000000000392. Epub 2014 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias